Schwenke H, Schönfelder M
Arch Geschwulstforsch. 1975;45(8):802-9.
Tumor cells of 30 patients suffering from different kinds of malignant tumors were established in culture. Various numbers of autologous and allogeneic PHA-stimulated as well as not stimulated lymphocytes were added to the cultures. 48 hours later, as evaluated by morphological observation, the lymphocytes caused a more or less cytotoxic effect in 80% of the cases, which is believed to be specific. This effect was distinctly inhibited in presence of the patient's own plasma in 71% in the sense of immunological enhancement. Cross reactivity between two patients having the same type of tumor was observed. The cytotoxic effect shows a certain correlation to the PHA transformation ability and increases with increasing numbers of lymphoid cells applied. It is supposed that in this manner the strength of an existing cell-mediated immunity against the tumor in every individual patient possibly can be assessed and, besides, an inhibiting humoral factor can be found out. Perhaps this can be valuable as an indicator for chemotherapy and immunotherapy of cancer.
对30例患有不同类型恶性肿瘤的患者的肿瘤细胞进行了培养。向培养物中添加了不同数量的自体和异体PHA刺激以及未刺激的淋巴细胞。48小时后,通过形态学观察评估,淋巴细胞在80%的病例中或多或少地产生了细胞毒性作用,据信这是特异性的。在患者自身血浆存在的情况下,这种作用在71%的情况下明显受到抑制,这意味着免疫增强。观察到两名患有相同类型肿瘤的患者之间存在交叉反应。细胞毒性作用与PHA转化能力呈一定相关性,并随着所应用淋巴细胞数量的增加而增强。据推测,通过这种方式,可能可以评估每个患者体内现有的针对肿瘤的细胞介导免疫的强度,此外,还可以找出一种抑制性体液因子。也许这可以作为癌症化疗和免疫治疗的有价值指标。